Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis
Meals, Mindfulness & Moving Forward: A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youth Suffering From Psychosis
Status: Enrolling
Updated:  9/19/2017
Oregon Health and Science University
mi
from
Portland, OR
A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis
Meals, Mindfulness & Moving Forward: A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youth Suffering From Psychosis
Status: Enrolling
Updated: 9/19/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Southern California Research
mi
from
Beverly Hills, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Southern California Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Southwestern Research
mi
from
Beverly Hills, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Southwestern Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Pharmacology Research Institute
mi
from
Encino, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Pharmacology Research Institute
mi
from
Newport Beach, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
PCSD - Feighner Research
mi
from
San Diego, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
PCSD - Feighner Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Research Across America
mi
from
Santa Ana, CA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Research Across America
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Lytle and Weiss, PLLC
mi
from
Denver, CO
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Lytle and Weiss, PLLC
mi
from
Denver, CO
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Miami Research Associates
mi
from
South Miami, FL
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Capstone Clinical Research
mi
from
Libertyville, IL
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Capstone Clinical Research
mi
from
Libertyville, IL
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
McLean Hospital
mi
from
Belmont, MA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Adams Clinical Trials LLC
mi
from
Watertown, MA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Adams Clinical Trials LLC
mi
from
Watertown, MA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Princeton Medical Institute, LCC
mi
from
Princeton, NJ
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Princeton Medical Institute, LCC
mi
from
Princeton, NJ
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Radiant Research, Inc.
mi
from
Akron, OH
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Radiant Research, Inc.
mi
from
Akron, OH
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Patient Priority Clinical sites, LLC
mi
from
Cincinnati, OH
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Patient Priority Clinical sites, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Lindner Center of HOPE
mi
from
Mason, OH
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Lindner Center of HOPE
mi
from
Mason, OH
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
IPS Research Company
mi
from
Oklahoma City, OK
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Sunstone Medical Research, LLC
mi
from
Medford, OR
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Oregon Center for Clinical Investigatons, INC.
mi
from
Portland, OR
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Oregon Center for Clinical Investigatons, INC.
mi
from
Portland, OR
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Oregon Center for Clinical Investigatons, INC.
mi
from
Salem, OR
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Oregon Center for Clinical Investigatons, INC.
mi
from
Salem, OR
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Radiant Research, Inc.
mi
from
Anderson, SC
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Radiant Research
mi
from
Greer, SC
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Furturesearch Trials of Dallas
mi
from
Dallas, TX
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Furturesearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Psychiatric Medical Associates
mi
from
Plano, TX
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Psychiatric Medical Associates
mi
from
Plano, TX
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Radiant Research, Inc.
mi
from
Murray, UT
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Radiant Research, Inc.
mi
from
Murray, UT
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Advanced Research Institute
mi
from
Ogden, UT
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Advanced Research Institute
mi
from
Ogden, UT
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Neuropsychiatric Associates
mi
from
Woodstock, VT
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Neuropsychiatric Associates
mi
from
Woodstock, VT
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
NeuroScience, Inc.
mi
from
Herndon, VA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Cypress Medical Research Center, LLC
mi
from
Wichita, KA
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Cypress Medical Research Center, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated:  9/20/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Dasotraline Binge Eating Disorder Study
A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Status: Enrolling
Updated: 9/20/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
AVIDA, Inc.
mi
from
Newport Beach, CA
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
AVIDA, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
Duke Univ Med Ctr
mi
from
Durham, NC
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
Prevention of Relapse to Opioid Addiction Using Depot Naltrexone
Status: Enrolling
Updated:  9/21/2017
Treatment Research Center
mi
from
Philadelphia, PA
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
Prevention of Relapse to Opioid Addiction Using Depot Naltrexone
Status: Enrolling
Updated: 9/21/2017
Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism
Status: Enrolling
Updated:  9/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism
Status: Enrolling
Updated: 9/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials